MedPath

A-04-01D-2

Phase 2
Conditions
Prevention of H5N1 influenza infection
Registration Number
JPRN-jRCT2080221139
Lead Sponsor
DENKA SEIKEN CO.,LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
300
Inclusion Criteria

Healthy volunteers

Exclusion Criteria

Known history of H5N1 influenza or received H5N1 influenza vaccination in the past.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Neutralizing antibody titer against H5N1 influenza virus <br>2. HI antibody titer against H5 antigen
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath